NGM

NGM Biopharmaceuticals, Inc. Common Stock
NGM

Overview Fund Activity
Delisted

NGM was delisted on the 4th of April, 2024.

Back to rankings

84 hedge funds and large institutions have $667M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
+11
Holders Change %
+15.07%
% of All Funds
1.73%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
21
Increased
32
Reduced
18
Closed
10
Calls
$13K
Puts
–
Net Calls
+$13K
Net Calls Change
+$13K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
$27.8M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
$30.1M
3
PS
Peter Svennilson
$350M
4
Morgan Stanley
Morgan Stanley
New York
$3.66M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
$1.6M

Top Sellers

1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$0
2
Citadel Advisors
Citadel Advisors
Florida
$551K
3
Marshall Wace
Marshall Wace
United Kingdom
$0
4
BBA
Baker Bros. Advisors
New York
$2.46M
5
Millennium Management
Millennium Management
New York
$231K
Name Holding Trade Value Shares
Change 		Shares
Change %
PS
1
Peter Svennilson
$350M +$7.58M +383,834 +2%
RCP
2
Rho Capital Partners
New York
$74.4M – – –
BlackRock
3
BlackRock
New York
$45.1M +$671K +33,968 +2%
GA
4
Greenspring Associates
Maryland
$31.1M – – –
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$30.1M +$10.4M +527,290 +53%
Vanguard Group
6
Vanguard Group
Pennsylvania
$27.8M +$18.5M +934,972 +197%
ACM
7
Aquilo Capital Management
California
$21.6M +$948K +48,000 +5%
State Street
8
State Street
Massachusetts
$9.17M +$110K +5,574 +1%
RSCM
9
Rock Springs Capital Management
Maryland
$7.06M +$125K +6,309 +2%
JRP
10
Jasper Ridge Partners
California
$6.1M – – –
Northern Trust
11
Northern Trust
Illinois
$5.17M -$54.5K -2,763 -1%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$4.82M +$189K +9,592 +4%
CS
13
Candriam SCA
Luxembourg
$4.52M -$261K -13,236 -5%
JPMorgan Chase & Co
14
JPMorgan Chase & Co
New York
$4.31M -$495K -25,091 -10%
Jacobs Levy Equity Management
15
Jacobs Levy Equity Management
New Jersey
$3.94M +$1.21M +61,432 +45%
Morgan Stanley
16
Morgan Stanley
New York
$3.66M +$3.61M +182,634 +6,326%
Renaissance Technologies
17
Renaissance Technologies
New York
$3.34M +$393K +19,900 +13%
BBA
18
Baker Bros. Advisors
New York
$2.46M -$2.48M -125,600 -50%
Nuveen Asset Management
19
Nuveen Asset Management
Illinois
$2.21M -$45.8K -2,320 -2%
Wells Fargo
20
Wells Fargo
California
$1.65M +$921K +46,661 +126%
SG Americas Securities
21
SG Americas Securities
New York
$1.63M +$1.42M +71,842 +684%
Charles Schwab
22
Charles Schwab
California
$1.62M +$26.7K +1,354 +2%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$1.6M -$21.8K -1,106 -1%
Arrowstreet Capital
24
Arrowstreet Capital
Massachusetts
$1.6M +$1.6M +81,016 New
Goldman Sachs
25
Goldman Sachs
New York
$1.19M +$313K +15,863 +36%
1
2 3 4